Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Shares Outstanding (Diluted Average) (2021 - 2022)

Catheter Precision (VTAK) has disclosed Shares Outstanding (Diluted Average) for 2 consecutive years, with $1.0 million as the latest value for Q4 2022.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 923.76% to $1.0 million in Q4 2022 year-over-year; TTM through Dec 2022 was $1.0 million, a 923.76% increase, with the full-year FY2022 number at $1.0 million, up 923.76% from a year prior.
  • Shares Outstanding (Diluted Average) was $1.0 million for Q4 2022 at Catheter Precision, up from $668.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.0 million in Q4 2022 to a low of $128.0 in Q3 2021.